Clinical Trial: A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Antibody-Associated Psychiatric Disease

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07093333) titled 'A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Antibody-Associated Psychiatric Disease' on June 19.

Brief Summary: This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of ART5803 in adult participants with a confirmed diagnosis of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis (ANRE) or anti-NMDAR antibody-associated psychiatric disease

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE) Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease Autoimmune Encephalitis

Interven...